参考文献/References:
[1] Xia Y,Shi L,Chang J,et al.Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine:A cross-sectional study based on the theory of planned behavior[J].Journal of Integrative Medicine,2021,19(3):219-225.
[2] 马月丹,王秀峰,吴华章,等. “十三五”期间中医医疗服务体系建设的成效与挑战[J].卫生经济研究,2020,37(6):5.
[3] Penchansky R,Thomas J W.The Concept of Access:Definition and Relationship to Consumer Satisfaction[J].Medical Care,1981,19(2): 127-140.
[4] Meng Q,Xu L,Zhang Y,et al. Trends in access to health services and financial protection in China between 2003 and 2011:a cross-sectional study[J].The Lancet, 2012,379(9818): 805-814.
[5] 马洪瑶,申俊龙,徐浩. 我国中医医疗服务价格现状浅析与改革初探[J].江苏中医药,2013,45(8):3.
[6] 李林贵. 浙江省8家县级中西医疗机构门诊经济学调查研究[J].中国卫生经济,2009,28(11):3.
[7] Bandura A.Human agency in social cognitive theory[J].American Psychologist,1989:10.
[8] Fishbein M,Ajzen I.Belief,attitude,intention,and behavior:An introduction to theory and research[J].Philosophy and Rhetoric,1977,10(2):30-31.
[9] Thompson A G H,Sunol R.Expectations as determinants of patient satisfaction:concepts,theory and evidence[J].International Journal for Quality in Health Care,1995,7(2):127-141.
[10] Blau P M.Social exchange and power in social life[M].New York:Wiley,1964.
[11] Keith J E,Lee D-J,Leem R G.The effect of relational exchange between the service provider and the customer on the customer’s perception of value[J].Journal of Relationship Marketing,2004,3(1):3-33.
[12] Macneil I R.The new social contract:An inquiry into modern contractual relations[J].Ethics,1982,93(1):545-547.
[13] Barry M J,Edgman-Levitan S.Shared decision making—the pinnacle of patient-centered care[J].New England Journal of Medicine,2012,366(9):780-781.
[14] 梁其姿.面对疾病:传统中国社会的医疗观念与组织[M].北京:中国人民大学出版社,2011.
[15] 李德新.中医基础理论讲稿[M].北京:人民卫生出版社,2008.
[16] French J R,Raven B,Cartwright D.The bases of social power[J].Classics of organization theory,1959,7: 311-320.
[17] 杜加辉,武东霞,王瑛.新时代中医药发展的机遇、挑战及对策[J].卫生经济研究,2019,36(6):3.
[18] 邓敏,肖增敏.基于社会学习的中医药服务认可度SEM改进分析[J].中国卫生政策研究, 2014,7(11):7.
[19] Verplanken B,Aarts H.Habit,Attitude,and planned behaviour:Is habit an empty construct or an interesting case of goal-directed automaticity?[J].European Review of Social Psychology,1999,10(1): 101-134.
[20] Moorman C.The effects of stimulus and consumer characteristics on the utilization of nutrition information[J].Journal of Consumer
Research,1990,17(3):362-374.
[21] Moorman C,Matulich E.A model of consumers’ preventive health
behaviors:the role of health motivation and health ability[J].Journal of Consumer Research,1993,20(2):208-228.
[22] Hausman A.Taking your medicine:relational steps to improving patient compliance[J].Health Marketing Quarterly,2001,19(2):49-71.
[23] Horne R,Weinman J,Barber N,et al.Concordance, adherence and compliance in medicine taking[J].London:NCCSDO,2005,2005:40-46.
[24] Cameron C.Patient compliance:recognition of factors involved and suggestions for promoting compliance with therapeutic regimens[J].Journal of Advanced Nursing,Wiley Online Library,1996,24(2):244-250.
[25] Hausman A V,Mader D.Measuring social aspects in the physician/patient relationship[J].Health Marketing Quarterly,2004,21(3):3-26.
[26] Raven B H,Schwarzwald J,Koslowsky M.Conceptualizing and measuring a power/interaction model of interpersonal influence[J].Journal of Applied Social Psychology,1998,28(4): 307-332.
[27] Henseler J,Ringle C M,Sarstedt M.A new criterion for assessing discriminant validity in variance-based structural equation modeling[J].Journal of the Academy of Marketing Science,2015, 43(1):115-135.
[28] A primer on partial least squares structural equation modeling (PLS-SEM)[M].J.F.Hair. Second edition.Los Angeles:Sage,2017.
相似文献/References:
[1]周引德,傅鸿鹏.基层医疗机构药品配备使用情况分析[J].卫生经济研究,2016,(05):38.
[2]路 云,张闪闪,李世勇.江苏省基本药物制度实施效果评价与思考[J].卫生经济研究,2017,(10):45.
[3]何 宇,杨小丽.试论精神卫生服务可及性的政府责任[J].卫生经济研究,2017,(12):31.
[4]刘 昉,李翠翠,马 健,等.基层用药公平可及性评价研究[J].卫生经济研究,2018,(04):46.
[5]许敏旋,贾莉英.我国全科医生资源集聚度评价分析[J].卫生经济研究,2018,(05):35.
[6]司明舒,苏 源,孔少楠,等.宁夏地区卫生资源配置研究[J].卫生经济研究,2018,(07):19.
[7]王海银,丛鹂萱,谢春艳,等.我国创新药品医保支付改革的进展及思考[J].卫生经济研究,2021,38(1):47.
WANG Hai-yin,CONG Li-xuan,XIE Chun-yan,et al.Progress and Consideration on the Medical Insurance Payment Reform for Innovative Drugs in China[J].Journal Press of Health Economics Research,2021,38(10):47.
[8]侯 颖,曹志辉.可避免住院标准的界定与影响因素:国际经验与启示[J].卫生经济研究,2021,38(7):55.
HOU Ying,CAO Zhi-hui.Definition and Influencing Factors of Avoidable Hospitalization Standards: International Experience and Enlightenment[J].Journal Press of Health Economics Research,2021,38(10):55.
[9]李奕昊,唐贵忠.罕见病用药可负担性评价及医保政策研究[J].卫生经济研究,2022,39(4):53.
LI Yi-hao,TANG Gui-zhong.Affordability Evaluation of Drugs for Rare Diseases and Research on Medical Insurance Policy[J].Journal Press of Health Economics Research,2022,39(10):53.
[10]陈子梦,王 丽,章 浴,等.基于供应链理论的我国孤儿药可及性分析与建议[J].卫生经济研究,2022,39(6):55.
CHEN Zimeng,WANG Li,ZHANG Yu,et al.Analysis and Suggestions on the Accessibility of Orphan Medicines in China Based on Supply Chain Theory[J].Journal Press of Health Economics Research,2022,39(10):55.